from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2811/-

LFCtreatmentdescriptionclass of inhibitor

-0.063

Amikacinug/mL Amikacintranslation

-0.317

Cap5-10ug/mL Capreomycintranslation

0.298

Rox10-50 ug/mL Roxithromycintranslation

-0.041

SM2-5 ug/mL Streptomycintranslation

0.722

Tet5-10 ug/mL Tetracyclinetranslation

-1.345

Rif0.2-5ug/mL Rifampicintranscription

-0.181

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.372

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.230

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.355

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.347

Clofazimine10-13 ug/mL Clofaziminerespiration

0.592

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.877

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.334

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.517

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.272

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.390

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.840

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.247

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.066

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.818

KCN5-20 ug/mL Potassium cyaniderespiration

0.346

NaN30.2-2 mM Sodium aziderespiration

0.094

Nigericin50 uM Nigericinrespiration

-0.205

TRC10-150 ug/mL Triclosanrespiration

-0.006

TRZ10-25 ug/mL Thioridazinerespiration

2.419

Valinomycin0.5-10 uM Valinomycinrespiration

-2.572

ZnSO42 mM ZnSO4respiration

-0.725

menadione6-10 ug/mL Menadionerespiration

0.357

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.095

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.070

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.296

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.409

NRP_1Non-replicating persistence stage 1dosRassociated

-0.021

Amp0.2mg/mL AmpicillincellWall

0.006

Cephalexin20-100 ug/mL CephalexincellWall

-0.142

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.423

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.770

EMB10-20 ug/mL EthambutolcellWall

0.324

Eta12-40 ug/mL EthionamidecellWall

0.799

INH0.2-0.4 ug/mL IsoniazidcellWall

0.039

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.861

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.145

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.067

BZA0.12 mg/mL BenzamidearomaticAmides

-0.211

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.642

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.034

H2O24 mM hydrogen peroxideDNAdamaging

-0.213

Levo10 ug/mL LevofloxacinDNAdamaging

-0.558

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.501

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.065

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.374

UVUV-irradiationDNAdamaging

0.407

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.041

Antimycin12.5-50 ug/mL Antimycin A?

-0.002

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.590

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.282

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.831

PA8240.2-2 ug/mL PA-824?

0.949

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.037

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.488

Verapamil50 uM Verapamil?

0.111

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.588

methoxatin10-20 ug/mL Methoxatin?